Alphapointe CEO: Competitor for big Army contract isn't playing fair

Although Alphapointe has developed a next-generation battlefield tourniquet, CEO Reinhard Mabry claims that the competitor holding the contract isn’t playing fair as the U.S. Army decides which one to use.
Kansas City-based Alphapointe is a nonprofit dedicated to providing jobs and assistance to the blind and visually impaired. In partnership with the U.S. Army, Alphapointe spent the past five years and $1 million developing a new battlefield tourniquet. Mabry said the design is vastly superior to the tourniquet currently in use because the Alphapointe model has a ratcheting device that allows it to be put on with only one hand.

Read Full Article